Avalon GloboCare (ALBT) Stock Chart & Stock Price History $2.24 +0.08 (+3.47%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Avalon GloboCare Stock Price Performance The Avalon GloboCare (ALBT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 49.93%, with a year-to-date return of -31.44%. In the past month, the stock has decreased 17.98%, reflecting recent market activity. As of the latest close, Avalon GloboCare traded at $2.16 with a market cap of $4.08 million and volume of 270,302 shares. Receive ALBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.45%1 Month Performance-17.98%3 Month Performance-41.95%Year-To-Date Performance-31.44%1 Year Performance-49.93% ALBT Stock Chart for Monday, August, 4, 2025 ALBT Chart by TradingView Avalon GloboCare Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$1.94$2.16+11.34%$2.24$1.87270,302 shs$4.08 million07/31/2025$2.08$1.94-6.73%$2.05$1.90165,357 shs$3.67 million07/30/2025$2.27$2.08-8.37%$2.20$2.05354,028 shs$3.94 million07/29/2025$2.97$2.27-23.57%$2.52$2.22683,635 shs$4.29 million07/28/2025$2.27$2.97+30.84%$4.74$2.4825.58 million shs$5.61 million07/25/2025$2.25$2.27+0.89%$2.28$2.2074,823 shs$4.29 million07/24/2025$2.38$2.25-5.46%$2.39$2.2397,045 shs$4.25 million07/23/2025$2.42$2.38-1.65%$2.49$2.3652,101 shs$4.50 million07/22/2025$2.32$2.42+4.31%$2.52$2.3183,893 shs$4.57 million07/21/2025$2.16$2.32+7.41%$2.35$2.1990,820 shs$4.39 million Get the Latest News and Ratings for ALBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$2.35$2.16-8.09%$2.37$2.16141,041 shs$4.08 million07/17/2025$2.42$2.35-2.89%$2.48$2.15314,101 shs$4.45 million07/16/2025$2.60$2.42-6.92%$2.54$2.35254,051 shs$4.57 million07/15/2025$2.71$2.60-4.06%$2.70$2.33508,854 shs$4.92 million07/14/2025$2.55$2.71+6.27%$3.15$2.5610.77 million shs$5.13 million07/11/2025$2.59$2.55-1.54%$2.73$2.54147,283 shs$4.83 million07/10/2025$2.68$2.59-3.36%$2.67$2.5624,913 shs$4.90 million07/09/2025$2.61$2.68+2.68%$2.74$2.5924,519 shs$5.07 million07/08/2025$2.55$2.61+2.35%$2.68$2.5269,417 shs$4.94 million07/07/2025$2.73$2.55-6.42%$2.74$2.5281,854 shs$4.82 million07/04/2025$2.73$2.73$2.81$2.6820,538 shs$5.16 million07/03/2025$2.79$2.73-2.33%$2.81$2.6820,538 shs$5.15 million Related Companies Moleculin Biotech Stock Chart Hoth Therapeutics Stock Chart Edesa Biotech Stock Chart NextCure Stock Chart Carisma Therapeutics Stock Chart Athira Pharma Stock Chart Neuphoria Therapeutics Stock Chart Mannatech Stock Chart Allarity Therapeutics Stock Chart Leap Therapeutics Stock Chart Receive ALBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALBT) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
